DOC

Healthcare real estate occupies a peculiar structural position in the American economy. It sits at the intersection of two of the most powerful secular forces in modern capitalism: the aging of the Baby Boom generation and the chronic undersupply of purpose-built medical facilities. Yet the companies that own and operate these properties rarely receive credit for structural importance. They are treated as yield instruments, valued on cap rates and dividend coverage ratios, and largely ignored by growth-oriented capital. Healthpeak Properties, now trading under the ticker DOC following its 2024 merger with Physicians Realty Trust, is the entity that most directly tests whether a healthcare REIT can transcend that yield-vehicle categorization.

The central analytical question for Healthpeak is not whether healthcare demand will grow. It will. The question is whether Healthpeak's portfolio composition, after the transformative Physicians Realty merger, creates a structural advantage that differentiates it from other healthcare REITs or whether it remains, like most of its peer group, a capital allocator whose returns are determined by forces largely outside its control: interest rates, tenant credit quality, government reimbursement policy, and demographic timing.

Healthpeak's merger with Physicians Realty Trust was not merely an accretive deal. It was a structural repositioning. The combined entity exited its remaining senior housing operating portfolio (SHOP) exposure through dispositions and pivoted decisively toward outpatient medical office buildings (MOBs) and life science properties. This makes Healthpeak the largest pure-play owner of outpatient medical real estate in the United States by square footage, and the most concentrated bet on the thesis that healthcare delivery is migrating permanently out of hospital campuses and into distributed outpatient settings. The insight that matters here is not the scale of the portfolio. It is the concentration of the bet. Healthpeak has made itself the landlord of a structural shift in how Americans receive medical care, and that shift is not reversible.

But concentration cuts both ways. A REIT that defines itself around a single property type and a single demand thesis is more exposed to cyclical and regulatory shocks than a diversified peer. The question for investors is whether the secular tailwind is strong enough, and Healthpeak's execution precise enough, to overcome the inherent vulnerability of concentration. This analysis maps that question across power, competition, dependency, and trajectory.